Esperion Therapeutics (LTS:0IIM) Common Stock : $0.2 Mil (As of Dec. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Esperion Therapeutics Common Stock?

Esperion Therapeutics's quarterly common stock stayed the same from Jun. 2024 ($0.2 Mil) to Sep. 2024 ($0.2 Mil) but then increased from Sep. 2024 ($0.2 Mil) to Dec. 2024 ($0.2 Mil).

Esperion Therapeutics's annual common stock increased from Dec. 2022 ($0.1 Mil) to Dec. 2023 ($0.1 Mil) and increased from Dec. 2023 ($0.1 Mil) to Dec. 2024 ($0.2 Mil).

Esperion Therapeutics Common Stock Historical Data

The historical data trend for Esperion Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Esperion Therapeutics Common Stock Chart

Esperion Therapeutics Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Common Stock

Get a 7-Day Free Trial

0.03

0.06

0.08

0.12

0.20

Esperion Therapeutics Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Common Stock	Get a 7-Day Free Trial															0.12	0.19	0.20	0.20	0.20

Esperion Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Esperion Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Esperion Therapeutics Inc (LTS:0IIM) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

ESPR:USA 0ET:Germany

Address

3891 Ranchero Drive, Suite 150, Ann Arbor, MI, USA, 48108

Website

https://www.esperion.com

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

Esperion Therapeutics Headlines

No Headlines